QLT optimistic about sales of flagship drug, despite decline in revenue (The Canadian Press via Yahoo! Canada News)
March 10th, 2010
QLT Inc. says it’s optimistic about the potential for revenue growth on its Visudyne treatment for age-related blindness despite seeing sales drop even as it divested itself of non-core products last year.
Original post by macular degeneration – Google News
(click on the author/publication link above to see full post)